Inpart

Helping a life sciences software company make a new acquisition legible, valuable, and strategically coherent.


Inova operated in the life sciences collaboration space, providing software that helps pharmaceutical and biotech teams manage external innovation, partnerships, and deal flow. Before the acquisition, Inova was already serving more than 150 global clients in biopharma, while IN-PART brought a complementary strength in matchmaking and early connection between academia and industry. Together, the opportunity was significant, but so was the communication challenge: how to explain the relationship between the two brands, make the acquired capabilities visible, and create a clearer story about what the combined business now offered.

I led the strategic work around that transition, facilitating multiple workshops with teams to help define the future brand architecture and sharpen how the business should present itself after the acquisition. The work included exploring naming options, clarifying the role of the acquired brand, and building a stronger platform for how Inova should talk about its own offer alongside IN-PART’s capabilities. The challenge was not simply to rename or reorganize, but to create a structure people could understand: one that reflected the logic of the business, made the combined strengths easier to see, and gave the company a more coherent foundation for growth.

The context made that clarity especially important. In biopharma and life sciences, partnerships, licensing, and external innovation have become increasingly central to growth, while the systems supporting those relationships have become more complex and more strategic. McKinsey has described external innovation and dealmaking as a critical lever for R&D productivity, and industry benchmarking has pointed to strong ongoing partnering activity and rising value in licensing and collaboration. In that kind of market, how a company organizes and communicates its offer is not just a branding question. It shapes whether the value of the platform is immediately understood.

The result was a strategic recommendation for a clearer brand architecture system, a naming direction, and a brand platform that helped the business talk about itself with more precision and confidence. It created a stronger basis for integrating the acquisition into a coherent story and for making the combined proposition more legible to customers, prospects, and internal teams alike.

Focus
Brand Architecture, Naming, Repositioning

Industry
Life Sciences, B2B SaaS

Stage
Post-Acquisition Growth

Services
Brand Architecture, Naming, Positioning, Narrative, Brand Platform, Workshop Facilitation

Previous
Previous

Blue Ocean Trade

Next
Next

Globall